Search results for: Innovation Policy Prize
Filter search results
Pricing in Emerging Markets: Income, Competition and Procurement
16 August 2011
…least some MLICs is. More generally, finding better mechanisms to enable differential pricing between and within low and middle income countries is an important challenge for firms and policymakers. Access…
New: Operationalising Value Based Pricing
11 August 2011
To date, the UK Government has not been specific about how VBP will be implemented, but has indicated that calculations of value will extend beyond the QALY approach currently used…
Recent Statistics on Orphan Approvals in Scotland and England
23 August 2011
In October 2009, the OHE published research that compared access to orphan medicinal products (OMPs) in selected European countries. At the request of the UK Orphan Medicines Industry Group [1],…
Upcoming OHE Seminars: MCDA and R&D Productivity
16 November 2011
…productivity in R&D in the pharmaceutical industry. He also will report results comparing productivity of US- and European-based companies, discussing the implications for EU R&D and industrial policy. Click here…
What is the True Value of Spending on Medical Research?
13 February 2012
Over the past four years, OHE has been involved in research intended to examine more thoroughly the economic value of medical research in the UK. Understanding and maximising the value…
Overview of the Economics of the Market for Medicines in the UK
29 March 2012
OHE’s Dr Jorge Mestre-Ferrandiz is a visiting lecturer in the Department of Economics at City University London. As part of his 2012 activities, he recently gave a comprehensive lecture on…
Can and Should Value Based Pricing Be Applied to Molecular Diagnostics?
1 May 2012
Just out is an OHE Research Paper that examines the issues. The authors note that diagnostics not only facilitate health gain and cost savings, but also provide information to inform…
New Seminar Briefing: Is Pharmaceutical R&D Experiencing a Productivity Crisis?
14 June 2012
Just published are the results of an OHE Lunchtime Seminar given by Prof Riccaboni, from the University of Trento. In this publication, he explores whether R&D productivity in the pharmaceutical…
Overview of the OHE Study on the Cost of Drug Development Presented
29 January 2013
OHE’s Jorge Mestre-Ferrandiz reviewed the results of OHE’s recent study on the R&D cost of developing a new drug at a seminar at University College London. Released in December 2012,…